Event-Driven Stocks

Lifeloc Technologies, Inc

LCTCOTC

Healthcare · Laboratory Analytical Instruments · CO · SEC filings ↗ · Compare ⊕

View price & chart on Yahoo Finance ↗
Signs4 good3 warningdetails ↓

Financials

SEC XBRL · annual
 FY25FY24FY23FY22FY21FY20
Revenue$9.0M$8.5M$9.3M$8.5M$7.1M$2.0M
Operating income−$1.2M−$1.4M−$191,135−$650,345−$268,913−$1.2M
Net income−$2.5M−$1.1M$205,614−$455,757$675,967−$165,306
Total assets$6.7M$8.7M$8.7M$8.5M$8.9M$8.5M
Total liabilities$2.6M$2.5M$2.3M$2.4M$2.4M$2.6M
Equity$4.1M$6.2M$6.4M$6.2M$6.6M$5.9M
EPS (diluted)$-0.90$-0.41$0.08$-0.19$0.27$-0.07
Shares out.2.7M2.5M2.5M2.5M2.5M2.5M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2025
Operating margin
−13.6%
Net margin
−27.4%
Return on equity
−60.2%
Return on assets
−36.9%
Return on capital (ROCE)
−21.0%
Liabilities / assets
38.6%
Debt / equity
0.63×
Book value / share
$1.54
Revenue growth (YoY)
5.7%
Net income growth (YoY)

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2025
Altman Z″ (distress)
2.91safe
Accruals / assets
29.5%clean
Beneish M-Score
-4.32normal
Piotroski F-Score
3/9weak

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
67
/ 100
Profitability 0Growth 100Catalyst 67Earnings quality 67Financial strength 100

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.

Signs

3 warning4 good
  • Operating losses (negative operating margin)
  • Reported a net loss
  • Negative operating cash flow
  • Revenue is growing year-over-year
  • Conservative leverage (liabilities < 50% of assets)
  • Clean earnings (low accruals)
  • Altman Z″ in the safe zone

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

5%+ owners

SEC Schedule 13D / 13G · last 3 yrs

Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.

Short interest

FINRA · bi-monthly
SettlementShares shortDays to coverΔ vs prior
Apr 15, 20263252.60.0%
Mar 31, 20263251.00.0%
Mar 13, 20263251.00.0%
Feb 27, 20263253.00.0%
Feb 13, 20263251.00.0%

Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Corporate family

Spin-offs from Lifeloc Technologies, Inc (1)

From the spin-off filings we track. Follow a company to walk its own history.

Event-driven situations (2)